256 related articles for article (PubMed ID: 34433808)
1. Combined intermittent fasting and ERK inhibition enhance the anti-tumor effects of chemotherapy via the GSK3β-SIRT7 axis.
Tang X; Li G; Shi L; Su F; Qian M; Liu Z; Meng Y; Sun S; Li J; Liu B
Nat Commun; 2021 Aug; 12(1):5058. PubMed ID: 34433808
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression and phosphorylation of Sirt7 activates smad2 and ERK signaling and promotes the cardiac fibrosis differentiation upon angiotensin-II stimulation.
Wang H; Liu S; Liu S; Wei W; Zhou X; Lin F; Wang J; Chen J; Zhang G; Pang Y
PLoS One; 2017; 12(6):e0178530. PubMed ID: 28582407
[TBL] [Abstract][Full Text] [Related]
3. SCF
Suber T; Wei J; Jacko AM; Nikolli I; Zhao Y; Zhao J; Mallampalli RK
J Biol Chem; 2017 May; 292(18):7452-7461. PubMed ID: 28298444
[TBL] [Abstract][Full Text] [Related]
4. SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.
Lu YF; Xu XP; Lu XP; Zhu Q; Liu G; Bao YT; Wen H; Li YL; Gu W; Zhu WG
Oncogene; 2020 Jun; 39(24):4650-4665. PubMed ID: 32404984
[TBL] [Abstract][Full Text] [Related]
5. Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
Dozza B; Smith MA; Perry G; Tabaton M; Strocchi P
J Neurochem; 2004 Jun; 89(5):1224-32. PubMed ID: 15147515
[TBL] [Abstract][Full Text] [Related]
6. Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis.
Elgendy M; Cirò M; Hosseini A; Weiszmann J; Mazzarella L; Ferrari E; Cazzoli R; Curigliano G; DeCensi A; Bonanni B; Budillon A; Pelicci PG; Janssens V; Ogris M; Baccarini M; Lanfrancone L; Weckwerth W; Foiani M; Minucci S
Cancer Cell; 2019 May; 35(5):798-815.e5. PubMed ID: 31031016
[TBL] [Abstract][Full Text] [Related]
7. Enhanced TLR4 Expression on Colon Cancer Cells After Chemotherapy Promotes Cell Survival and Epithelial-Mesenchymal Transition Through Phosphorylation of GSK3β.
Chung YH; Kim D
Anticancer Res; 2016 Jul; 36(7):3383-94. PubMed ID: 27354597
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells.
Weikel KA; Cacicedo JM; Ruderman NB; Ido Y
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27534430
[TBL] [Abstract][Full Text] [Related]
9. TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation.
Wu H; Lu XX; Wang JR; Yang TY; Li XM; He XS; Li Y; Ye WL; Wu Y; Gan WJ; Guo PD; Li JM
Autophagy; 2019 Sep; 15(9):1506-1522. PubMed ID: 30806153
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer.
Yu H; Ye W; Wu J; Meng X; Liu RY; Ying X; Zhou Y; Wang H; Pan C; Huang W
Clin Cancer Res; 2014 Jul; 20(13):3434-45. PubMed ID: 24771643
[TBL] [Abstract][Full Text] [Related]
11. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM
Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973
[TBL] [Abstract][Full Text] [Related]
12. Nrf2-mediated liver protection by esculentoside A against acetaminophen toxicity through the AMPK/Akt/GSK3β pathway.
Wang L; Zhang S; Cheng H; Lv H; Cheng G; Ci X
Free Radic Biol Med; 2016 Dec; 101():401-412. PubMed ID: 27836781
[TBL] [Abstract][Full Text] [Related]
13. SIRT7 promotes thyroid tumorigenesis through phosphorylation and activation of Akt and p70S6K1 via DBC1/SIRT1 axis.
Li H; Tian Z; Qu Y; Yang Q; Guan H; Shi B; Ji M; Hou P
Oncogene; 2019 Jan; 38(3):345-359. PubMed ID: 30093629
[TBL] [Abstract][Full Text] [Related]
14. Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response.
Kiran S; Oddi V; Ramakrishna G
Exp Cell Res; 2015 Feb; 331(1):123-141. PubMed ID: 25445786
[TBL] [Abstract][Full Text] [Related]
15. SIRT7 depletion inhibits cell proliferation, migration, and increases drug sensitivity by activating p38MAPK in breast cancer cells.
Chen KL; Li L; Yang FX; Li CM; Wang YR; Wang GL
J Cell Physiol; 2018 Sep; 233(9):6767-6778. PubMed ID: 29231244
[TBL] [Abstract][Full Text] [Related]
16. ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons.
Hetman M; Hsuan SL; Habas A; Higgins MJ; Xia Z
J Biol Chem; 2002 Dec; 277(51):49577-84. PubMed ID: 12393899
[TBL] [Abstract][Full Text] [Related]
17. An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta.
Miyashita K; Nakada M; Shakoori A; Ishigaki Y; Shimasaki T; Motoo Y; Kawakami K; Minamoto T
Anticancer Agents Med Chem; 2009 Dec; 9(10):1114-22. PubMed ID: 19925395
[TBL] [Abstract][Full Text] [Related]
18. Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer.
Gwak H; Kim Y; An H; Dhanasekaran DN; Song YS
Mol Carcinog; 2017 Feb; 56(2):349-358. PubMed ID: 27128966
[TBL] [Abstract][Full Text] [Related]
19. Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells.
Santha S; Davaakhuu G; Basu A; Ke R; Das S; Rana A; Rana B
Oncotarget; 2016 Oct; 7(41):66892-66905. PubMed ID: 27602497
[TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
Kim EJ; Juhnn YS
J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
